nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A nationwide pathology study on surgical margins and excision volumes after breast-conserving surgery: There is still much to be gained
|
Haloua, M.H. |
|
2016 |
25 |
C |
p. 14-21 8 p. |
artikel |
2 |
Biological and clinical significance of loss of heterozygosity at the INPP4B gene locus in Japanese breast cancer
|
Tokunaga, Eriko |
|
2016 |
25 |
C |
p. 62-68 7 p. |
artikel |
3 |
Brain natriuretic peptide as a cardiac marker of transient radiotherapy-related damage in left-sided breast cancer patients: A prospective study
|
Palumbo, I. |
|
2016 |
25 |
C |
p. 45-50 6 p. |
artikel |
4 |
Corrigendum to “Gene expression profiling in breast cancer: A clinical perspective” [The Breast 22 (2013) 109–120]
|
Arpino, Grazia |
|
2016 |
25 |
C |
p. 86- 1 p. |
artikel |
5 |
Ductal carcinoma in situ (DCIS) treated by mastectomy, or local excision with or without radiotherapy: A monocentric, retrospective study of 608 women
|
Frank, Sophie |
|
2016 |
25 |
C |
p. 51-56 6 p. |
artikel |
6 |
Eliminating “ductal carcinoma in situ” and “lobular carcinoma in situ” (DCIS and LCIS) terminology in clinical breast practice: The cognitive psychology point of view
|
Pravettoni, Gabriella |
|
2016 |
25 |
C |
p. 82-85 4 p. |
artikel |
7 |
Evaluating the quality of internet information for breast cancer
|
Nghiem, A.Z. |
|
2016 |
25 |
C |
p. 34-37 4 p. |
artikel |
8 |
Hormonal receptor status, Ki-67 and HER2 expression: Prognostic value in the recurrence of ductal carcinoma in situ of the breast?
|
Poulakaki, Nikiforita |
|
2016 |
25 |
C |
p. 57-61 5 p. |
artikel |
9 |
Information requirements of young women with breast cancer treated with mastectomy or breast conserving surgery: A systematic review
|
Recio-Saucedo, Alejandra |
|
2016 |
25 |
C |
p. 1-13 13 p. |
artikel |
10 |
Nipple sparing mastectomy: Surgical and oncological outcomes from a national multicentric registry with 913 patients (1006 cases) over a six year period
|
Orzalesi, Lorenzo |
|
2016 |
25 |
C |
p. 75-81 7 p. |
artikel |
11 |
Psychiatric morbidity and non-participation in breast cancer screening
|
Jensen, Line Flytkjær |
|
2016 |
25 |
C |
p. 38-44 7 p. |
artikel |
12 |
Publisher's note
|
|
|
2016 |
25 |
C |
p. 87- 1 p. |
artikel |
13 |
Reviewer acknowledgement 2015
|
|
|
2016 |
25 |
C |
p. 88-89 2 p. |
artikel |
14 |
Risk factors for brain metastasis as a first site of disease recurrence in patients with HER2 positive early stage breast cancer treated with adjuvant trastuzumab
|
Tonyali, Onder |
|
2016 |
25 |
C |
p. 22-26 5 p. |
artikel |
15 |
The use of granulocyte colony stimulating factor (G-CSF) and management of chemotherapy delivery during adjuvant treatment for early-stage breast cancer—Further observations from the IMPACT solid study
|
Mäenpää, Johanna |
|
2016 |
25 |
C |
p. 27-33 7 p. |
artikel |
16 |
Vitamin D (25-0H D3) status and pathological response to neoadjuvant chemotherapy in stage II/III breast cancer: Data from the NEOZOTAC trial (BOOG 10-01)
|
Charehbili, A. |
|
2016 |
25 |
C |
p. 69-74 6 p. |
artikel |